Studies on the amyloid PET imaging in patients with dementia
Not Applicable
- Conditions
- patients with dementia
- Registration Number
- JPRN-UMIN000010767
- Lead Sponsor
- Mie University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with dementia without multiple cerebral microbleeds and/or cortical microinfarcts on MRI
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method accurate clinical diagnosis of mixed dementia
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of amyloid-beta aggregation are studied in JPRN-UMIN000010767 PET imaging trials for dementia?
How does amyloid PET imaging compare to FDG-PET and MRI in diagnosing Alzheimer's disease and other dementia subtypes?
Which biomarkers correlate with amyloid PET imaging outcomes in early-onset vs. late-onset Alzheimer's disease?
What are the safety profiles of amyloid PET tracers like florbetapir and flutemetamol in dementia clinical trials?
Are there combination imaging strategies with amyloid PET and tau PET for improved dementia diagnosis and progression monitoring?